North West London is taking part in the national NHS rollout of Mounjaro (Tirzepatide), a new obesity treatment aimed at individuals with serious weight-related health conditions.
The programme is being introduced in stages, with around 900 people in North West London expected to be eligible in the first phase. Timings for the rollout are still to be confirmed.
Eligibility Criteria:
Individuals must:
- Be 18+ years old
- Have a BMI of 40+ (or 37.5+ for some ethnic groups) Not sure what your BMI is? Click here
- Have at least four obesity-related conditions, such as:
- Type 2 Diabetes
- High Blood Pressure
- High Cholesterol
- Cardiovascular Disease
- Sleep Apnoea
Prescribed only within a structured programme. Along with diet, activity and behavioural support
For Others Not Yet Eligible:
You can still access support via:
- Speak with your GP for referral to Local Tier 3 services. Sumbit a request online via Patchs
For more information on the Northwest London roll out of Tirzepatide (Mounjaro) Click here